Benefit-Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis.

Comi, Giancarlo

Benefit-Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis. [electronic resource] - Drugs Oct 2017 - 1755-1768 p. digital

Publication Type: Journal Article; Review

1179-1950

10.1007/s40265-017-0814-1 doi


Fingolimod Hydrochloride--administration & dosage
Humans
Immunosuppressive Agents--administration & dosage
Multiple Sclerosis--diagnosis
Natalizumab--administration & dosage
Receptors, Lysosphingolipid--metabolism
Risk Assessment